Citation Impact
Citing Papers
Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer
2018
Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤3 cm: accuracy and interobserver agreement
2014
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition
2015
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
2019 Standout
Astrocytes: biology and pathology
2009 Standout
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
2016
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection
2018
A view on drug resistance in cancer
2019 StandoutNature
Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
2014
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
The Blood–Brain Barrier
2015 Standout
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Wnt signaling in cancer
2016 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Vessel co-option in cancer
2019
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma
2016
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Aquaporin water channels in the nervous system
2013
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
“Lest we forget you — methylene blue …”
2011
Synthetic organic dyes as contaminants of the aquatic environment and their implications for ecosystems: A review
2020 Standout
Consensus guidelines for diagnosis, prophylaxis and management of P neumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014
2014
Lung cancer: current therapies and new targeted treatments
2016 Standout
Precision medicine in cholangiocarcinoma
2018
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Identification of neutral tumor evolution across cancer types
2016
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Structure and Functions of Aquaporin-4-Based Orthogonal Arrays of Particles
2011
Deep learning in histopathology: the path to the clinic
2021 Standout
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: A role in innate immunity?
2010
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
The Glymphatic System: A Beginner’s Guide
2015 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Pathology and new players in the pathogenesis of brain edema
2009
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Gastric cancer
2020 Standout
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
2016
A fate worse than death: apoptosis as an oncogenic process
2016
Applications of machine learning in drug discovery and development
2019 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Wnt–β-catenin signalling in liver development, health and disease
2018
ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer
2014
The disturbed blood–brain barrier in human glioblastoma
2012
Mitochondria as multifaceted regulators of cell death
2019 Standout
Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics
2017
Digital pathology and artificial intelligence
2019 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
2014
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Overview of Cellular Immunotherapy for Patients with Glioblastoma
2010
Artificial intelligence in healthcare
2018 Standout
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Association Between Pharmaceutical Support and Basic Science Research on Erythropoiesis-Stimulating Agents
2010
Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer
2015
Special Treatment Issues in Non-small Cell Lung Cancer
2013
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features
2016
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer
2019
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction
2018 Standout
Metastasis as an evolutionary process
2016 Science
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF‐A and TGFβ2 in vascular abnormalization
2012
Spermidine in health and disease
2018 StandoutScience
Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity
2018
Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer
2020
Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival
2014
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
2015
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Industry sponsorship and research outcome
2017 Standout
Works of Benjamin Goeppert being referenced
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
2014
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
2013
Ataxia-telangiectasia–Mutated Protein Kinase Levels Stratify Patients With Pancreatic Adenocarcinoma Into Prognostic Subgroups With Loss Being a Strong Indicator of Poor Survival
2014
Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma
2015
HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients
2011
De novo erythropoietin receptor (EPO‐R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival
2007
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma
2013
Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells
2007
EGFR,KRAS,BRAFandALKgene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype
2013
Turquoise to dark green organs at autopsy
2009
Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway
2013
Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival
2010
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas
2012
Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer
2015
Targeting heat shock protein 90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma #
2009
Expression pattern of the water channel aquaporin‐4 in human gliomas is associated with blood–brain barrier disturbance but not with patient survival
2007
2014
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma
2016
Integrated Histogenetic Analysis Reveals BAP1 -Mutated Epithelioid Mesothelioma in a Patient With Cancer of Unknown Primary
2018
The BH3‐only protein BID impairs the p38‐mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice
2015